Similar Papers

Paper Title
Journal
Date
Author
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Gao-Min Liu ... Yao-Min Zhang
Cancer Cell International | VOL. 19
Gao-Min Liu, et. al.Gao-Min Liu ... Yao-Min Zhang
29 Jan 2019
The Prognostic Value of PD-L1 Expression in Triple-Negative Breast Cancer: A Cohort Study and Systematic Literature Review
Daniel Schmolze ... Carolyn E Behrendt
Pathology and Laboratory Medicine – Open Journal | VOL. 2
Daniel Schmolze, et. al.Daniel Schmolze ... Carolyn E Behrendt
30 Dec 2020
Data from Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Kurt A Schalper ... Roy S Herbst
-
Kurt A Schalper, et. al.Kurt A Schalper ... Roy S Herbst
31 Mar 2023
Data from Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Kurt A Schalper ... Roy S Herbst
-
Kurt A Schalper, et. al.Kurt A Schalper ... Roy S Herbst
31 Mar 2023
View more papers

More From: Hong Kong Journal of Radiology

Paper Title
Journal
Date
Author
Adrenal Venous Sampling for Recognising the Many Variants of Adrenal Veins: A Pictorial Essay
Ccy Chan ... Dhy Cho
Hong Kong Journal of Radiology | VOL. -
Ccy Chan, et. al.Ccy Chan ... Dhy Cho
18 Dec 2024
Clinical Implications of Erb-B2 Receptor Tyrosine Kinase 2 S310 Mutations in Non–Small-Cell Lung Cancer: Two Case Reports
Q Du ... Mw Yeung
Hong Kong Journal of Radiology | VOL. -
Q Du, et. al.Q Du ... Mw Yeung
03 Dec 2024
Validation of Artificial Intelligence for Bone Age Assessment in Hong Kong Children
C Cheung ... Eyl Kan
Hong Kong Journal of Radiology | VOL. -
C Cheung, et. al.C Cheung ... Eyl Kan
28 Nov 2024
Pembrolizumab with or without Concurrent Chemotherapy in Metastatic Non–Small-Cell Lung Cancer with High Programmed Death Ligand 1 Expression
Dhz Lui ... My Lim
Hong Kong Journal of Radiology | VOL. -
Dhz Lui, et. al.Dhz Lui ... My Lim
19 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.